admin | Dr. Know

Six in ten people with COVID-19 still have a least one symptom a year later, long Covid study reveals

by admin | Apr 26, 2022 | Breaking News Express-SR

Sorry, this entry is only available in 中文.類型: 連結出處: Luxembourg Institute of Health 連結:...

Six in ten people with COVID-19 still have a least one symptom a year later, long Covid study reveals

by admin | Apr 26, 2022 | Breaking News Express-SR

Sorry, this entry is only available in 中文.類型: 連結出處: Luxembourg Institute of Health 連結:...

Six in ten people with COVID-19 still have a least one symptom a year later, long Covid study reveals

by admin | Apr 26, 2022 | Clinical Manifestations, Transmission, Epidemiology, Virus, Pathophysiology

Sorry, this entry is only available in 中文.類型: 連結出處: Luxembourg Institute of Health 連結:...

FDA Approves First COVID Treatment for Younger Kids

by admin | Apr 25, 2022 | Medical Health, Facility Staff, Medications

Sorry, this entry is only available in 中文.類型: 連結作者: Molly Walker 出處: MedpageToday 連結:...

COVID-19 and the Brain: The Neuropathological Italian Experience on 33 Adult Autopsies

by admin | Apr 25, 2022 | Virology, Pathophysiology

Sorry, this entry is only available in 中文.類型: PDF 作者: Viscardo P. Fabbri et al. 出處: Biomolecules 附件: PDF文件

Computational identification of Shenshao Ningxin Yin as an effective treatment for novel coronavirus infection (COVID-19) with myocarditis

by admin | Apr 23, 2022 | Chinese and Western Therapeutic Pharmacological Research

Our findings reveal the pharmacological role and molecular mechanism of SNY for the treatment of COVID-19 with myocarditis. We also, for the first time, demonstrate that SNY displays multi-component, multi-target, and multi-pathway characteristics with a complex mechanism of action.